FAScinate Therapeutics, Inc. announced a private placement of 9,850,000 common shares at a price of KRW 1,837.5635 per share for gross proceeds of KRW 18,100,000,475 in July 2020. The transaction included participation from returning investor Kainos Medicine, Inc. (KOSDAQ:A284620) to retain its 100% stake in the company.